文献速递脑血管病神经肌肉病神经免疫

患者前往神经科医生就诊的出行距离

Patient Travel Distance to Neurologist Visits.
PubMed 文献 · Neurology · 2023-09-13

该研究基于2018年医疗保险样本进行横断面分析,纳入至少1次门诊神经科就诊的563,216名受益人,发现17%的患者单程驾车≥50英里,长途出行在神经系统癌症(39.6%)、肌萎缩侧索硬化(32.1%)和多发性硬化(22.8%)中最为常见,神经科医生密度低和农村地区是重要预测因素。

要点

  • 17%的神经科就诊患者单程驾车≥50英里,长途出行中位距离81.3英里、时间90分钟。
  • 长途出行在神经系统癌症(39.6%)、肌萎缩侧索硬化(32.1%)和多发性硬化(22.8%)中最为常见。
  • 神经科医生密度低(OR 3.04)和农村地区(OR 4.89)与长途出行相关。

核心结论

  • 近1/5的神经科就诊医保受益人单程出行≥50英里,长途负担在需协调多学科诊疗的低患病率神经系统疾病中最为常见。
  • 神经科医生密度低和农村 location 是重要的潜在可干预预测因素,提示可通过远程医疗或神经专科医生支持 local 神经科医生来改善就医可及性。
  • 未来工作应评估长途出行与未长途出行患者之间临床结局的差异。

研究设计与样本

  • 横断面分析,使用2018年医疗保险样本中至少1次门诊神经科就诊的患者。
  • 长途出行定义为单程驾车距离≥50英里,出行时间以驾车分钟数衡量。
  • 采用多水平广义线性混合模型(logistic链接函数),考虑患者在医院转诊区域内的聚类并允许区域特定随机效应,以确定患者和区域特征与长途出行的关联。

主要发现

  • 共识别563,216名2018年有神经科就诊的医疗保险受益人,其中96,213人(17%)为长途出行。
  • 长途出行患者的中位驾车距离和时间为81.3英里(四分位距[IQR]:59.9-144.2)和90分钟(IQR:69-149),非长途出行患者分别为13.2英里(IQR:6.5-23)和22分钟(IQR:14-33)。
  • 长途出行在神经系统癌症(39.6%)、肌萎缩侧索硬化(32.1%)和多发性硬化(22.8%)中最为常见。
  • 与长途出行相关的因素包括神经科医生密度低(第一五分位 vs 第五五分位:OR 3.04 [95% CI 2.41-3.83])、农村环境(OR 4.89 [95% CI 4.79-4.99])、因初级保健医生就诊而长途出行(OR 3.6 [95% CI 3.51-3.69])、以及因肌萎缩侧索硬化和神经系统癌症就诊(OR分别为3.41 [95% CI 3.14-3.69]和5.27 [95% CI 4.72-5.89])。
  • 近1/3的患者绕过最近的神经科医生20英里以上,7.3%的患者跨州接受神经科诊疗。

临床怎么用

  • 作者认为,神经科医生密度低和农村 location 是潜在可干预的预测因素,提示可通过远程医疗或神经专科医生支持 local 神经科医生等干预改善就医可及性。
  • 作者建议未来工作应评估长途出行与未长途出行患者之间临床结局的差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: The density of neurologists within a given geographic region varies greatly across the United States. We aimed to measure patient travel distance and travel time to neurologist visits, across neurologic conditions and subspecialties. Our secondary goal was to identify factors associated with long-distance travel for neurologic care. METHODS: We performed a cross-sectional analysis using a 2018 Medicare sample of patients with at least 1 outpatient neurologist visit. Long-distance travel was defined as driving distance ≥50 miles 1-way to the visit. Travel time was measured as driving time in minutes. Multilevel generalized linear mixed models with logistic link function, which accounted for clustering of patients within hospital referral region and allowed modeling of region-specific random effects, were used to determine the association of patient and regional characteristics with long-distance travel. RESULTS: We identified 563,216 Medicare beneficiaries with a neurologist visit in 2018. Of them, 96,213 (17%) traveled long distance for care. The median driving distance and time were 81.3 (interquartile range [IQR]: 59.9-144.2) miles and 90 (IQR: 69-149) minutes for patients with long-distance travel compared with 13.2 (IQR: 6.5-23) miles and 22 (IQR: 14-33) minutes for patients without long-distance travel. Comparing across neurologic conditions, long-distance travel was most common for nervous system cancer care (39.6%), amyotrophic lateral sclerosis [ALS] (32.1%), and MS (22.8%). Many factors were associated with long-distance travel, most notably low neurologist density (first quintile: OR 3.04 [95% CI 2.41-3.83] vs fifth quintile), rural setting (4.89 [4.79-4.99]), long-distance travel to primary care physician visit (3.6 [3.51-3.69]), and visits for ALS and nervous system cancer care (3.41 [3.14-3.69] and 5.27 [4.72-5.89], respectively). Nearly one-third of patients bypassed the nearest neurologist by 20+ miles, and 7.3% of patients crossed state lines for neurologist care. DISCUSSION: We found that nearly 1 in 5 Medicare beneficiaries who saw a neurologist traveled ≥50 miles 1-way for care, and travel burden was most common for lower-prevalence neurologic conditions that required coordinated multidisciplinary care. Important potentially addressable predictors of long-distance travel were low neurologist density and rural location, suggesting interventions to improve access to care such as telemedicine or neurologic subspecialist support to local neurologists. Future work should evaluate differences in clinical outcomes between patients with long-distance travel and those without.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Lin CC, Hill CE, Kerber KA, et al. Patient Travel Distance to Neurologist Visits. Neurology. 2023. PMID: 37704403. doi:10.1212/WNL.0000000000207810

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。